# Semax - Semax (MEHFPGP) - an ACTH(4-10) analog peptide, developed in Russia and supplied freeze-dried for laboratory research. Semax (MEHFPGP) ACTH-analog research-use-only peptide - freeze-dried, catalog lot details, dispatched from Perth. ## At a glance | | | | --- | --- | | Compound | Semax | | Descriptor | ACTH-fragment peptide study material | | Current certificate | Not verified for listed lot | | Storage | 2-8 C | | Format | Freeze-dried powder | | Availability | In stock | | Lot | SEMAX-2506 | ## Sizes and pricing (AUD) | | | | --- | --- | | 11 mg | $89 AUD | ## Certificate status Matching current certificate unavailable. No verified report matches the listed compound, lot and amount. Historical sample report: Semax, 11 mg, lot FL20260410-SEMAX-11. Test: Heavy metals analysis. This report does not verify the listed item or lot; a document mismatch does not establish the physical product's contents. ## What Semax is Semax is the common name for a synthetic heptapeptide with the sequence MEHFPGP (Met-Glu-His-Phe-Pro-Gly-Pro), described in the research literature as an ACTH(4-10) analog. The published work spans lab and animal studies, research on how the peptide breaks down, and a body of clinical research carried out in Russia, where Semax is registered as a medicine - though not approved by the TGA, the FDA, or EU regulators. Form Laboratories points to those papers as identity and study context only - not as claims about this product. The historical 11 mg report covers FL20260410-SEMAX-11, not SEMAX-2506. It does not establish current identity, purity or release status. ## Specifications The basics at a glance: sequence, CAS, formula, molecular weight, format, storage, and the current batch. A sample report only covers the compound, amount, lot and tests it names. | | | | --- | --- | | Compound | Semax | | Sequence | Met-Glu-His-Phe-Pro-Gly-Pro / MEHFPGP | | Length | 7 amino acids | | CAS | 80714-61-0 | | Molecular formula | C37H51N9O10S | | Molecular weight | 813.93 g/mol | | Structure note | ACTH(4-10) analog; ACTH(4-7)-Pro-Gly-Pro | | Format | Freeze-dried research reference | | Storage | 2-8 C, protect from light | | Lot | SEMAX-2506 | ## What the research looks at Semax is described in published studies as a heptapeptide built from a fragment of ACTH, studied mainly for its role in neuroprotection, cognition, and BDNF research. Researchers use those papers to compare animal studies, enzyme-stability research, gene-expression work, and the clinical studies carried out in Russia. Published studies and historical sample reports do not establish release status for this listed lot. ## Frequently asked questions ### What is Semax supplied for? Semax is supplied as laboratory research material only. It is 21+ only, not for human consumption, and not for veterinary use. ### Does this page include matching COA information? The product page lists catalog lot, appearance and storage notes for Semax. Available original reports are labelled by sample; matching current certification is unavailable where the compound, lot or amount differs. A heavy-metals screen does not measure purity or confirm identity. ### How should the vial be handled after delivery? Follow the label and your laboratory's written procedures. Do not treat a historical sample report as current lot documentation. This page repeats 2-8 C storage guidance and light-protection notes before checkout. ### What is Semax? Semax is a lab-made heptapeptide known in research by its sequence, MEHFPGP (Met-Glu-His-Phe-Pro-Gly-Pro), and described as an ACTH(4-10) analog. It was developed in Russia, where it is registered as a medicine, and has been studied since the 1980s for its role in neuroprotection and cognition research. The spec sheet lists it with formula C37H51N9O10S and a molecular weight of 813.93 g/mol. Form Laboratories supplies it freeze-dried for laboratory research only. ### Is Semax approved for human use? Semax is registered as a medicine in Russia, where it was developed. It is not approved by the TGA (Australia), the FDA (US), or EU regulators, and that regulatory context is stated on the page so the research record stays honest. Form Laboratories supplies it only as research-use-only reference material, not as a medicine and not for human or veterinary use. ### Which batch and storage apply to Semax? The current batch is lot SEMAX-2506, supplied as an 11 mg freeze-dried vial. The spec sheet lists storage at 2-8 C, protected from light. The lab report on file is a Janoshik heavy-metals screen, which reports arsenic, cadmium and mercury as not detected; it does not measure purity and does not confirm identity. Matching current certification is unavailable; these are catalog and historical sample details, not current test findings or use instructions. ## References - Dolotov 2006: Dolotov OV et al. Brain Res. 2006;1117:54-60. DOI: 10.1016/j.brainres.2006.07.108 - Gusev 2018: Gusev EI et al. Zh Nevrol Psikhiatr. 2018. DOI: 10.17116/jnevro20181183261-68 - Filippenkov 2020: Filippenkov IB et al. Genes (Basel). 2020;11(6):681. DOI: 10.3390/genes11060681 This summary is for scientific and educational context only. It is not preparation guidance, administration guidance, or a statement about use in people or animals. --- Canonical page: https://www.formlaboratories.com/shop/semax Form Laboratories - Perth-based research-use-only peptide supplier, shipping Australia-wide. - Site guide for agents: https://www.formlaboratories.com/llms.txt - Sitemap: https://www.formlaboratories.com/sitemap.xml - Full catalogue: https://www.formlaboratories.com/shop - Contact: hello@formlaboratories.com All materials are supplied for laboratory research use only - not for human or veterinary use, and nothing on this site is medical advice.